These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34356603)

  • 1. Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19.
    Moore GJ; Pires JM; Kelaidonis K; Gadanec LK; Zulli A; Apostolopoulos V; Matsoukas JM
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
    Moore GJ; Ridgway H; Kelaidonis K; Chasapis CT; Ligielli I; Mavromoustakos T; Bojarska J; Matsoukas JM
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
    Ridgway H; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Hoffmann W; Węgrzyn K; Vassilaki N; Mpekoulis G; Zouridakis M; Giastas P; Vidali VP; Kelaidonis K; Matsoukas MT; Dimitriou M; Mavromoustakos T; Tsiodras S; Gorgoulis VG; Karakasiliotis I; Chasapis CT; Matsoukas JM
    Expert Opin Ther Targets; 2024 May; 28(5):437-459. PubMed ID: 38828744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
    El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers.
    Miura S; Nakao N; Hanzawa H; Matsuo Y; Saku K; Karnik SS
    PLoS One; 2013; 8(11):e79914. PubMed ID: 24260317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood-Brain Barrier.
    Moore GJ; Ridway H; Gadanec LK; Apostolopoulos V; Zulli A; Swiderski J; Kelaidonis K; Vidali VP; Matsoukas MT; Chasapis CT; Matsoukas JM
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
    Caputo I; Caroccia B; Frasson I; Poggio E; Zamberlan S; Morpurgo M; Seccia TM; Calì T; Brini M; Richter SN; Rossi GP
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.
    Zimmerman MA; Harris RA; Sullivan JC
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1136-42. PubMed ID: 24647710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.
    Matsoukas J; Apostolopoulos V; Zulli A; Moore G; Kelaidonis K; Moschovou K; Mavromoustakos T
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33504092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.
    Gadanec LK; Swiderski J; Apostolopoulos V; Kelaidonis K; Vidali VP; Canko A; Moore GJ; Matsoukas JM; Zulli A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
    Melissa Hallow K; Dave I
    Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2010 Dec; 10(14):1366-84. PubMed ID: 20937029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.
    Ridgway H; Moore GJ; Mavromoustakos T; Tsiodras S; Ligielli I; Kelaidonis K; Chasapis CT; Gadanec LK; Zulli A; Apostolopoulos V; Petty R; Karakasiliotis I; Gorgoulis VG; Matsoukas JM
    Comput Struct Biotechnol J; 2022; 20():2091-2111. PubMed ID: 35432786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARB and cardioprotection.
    Akazawa H; Yabumoto C; Yano M; Kudo-Sakamoto Y; Komuro I
    Cardiovasc Drugs Ther; 2013 Apr; 27(2):155-60. PubMed ID: 22538956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out.
    Kiya Y; Miura S; Matsuo Y; Karnik SS; Saku K
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):76-83. PubMed ID: 21824992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peptide and nonpeptide antagonists of angiotensin II receptors on noradrenaline release in hypothalamus of rats with angiotensin II-induced increase of water intake.
    Stancheva S; Alova L; Stefanova M
    Pharmacol Rep; 2009; 61(6):1206-10. PubMed ID: 20081258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.